Theravance, Inc. (THRX)

$13.66 -0.38 (-2.71%)

11/23/2009 4:00 PM

CAPS Rating

Open

$14.25

Previous Close

$14.04

Daily Range

$13.40 - $14.39

52-Week Range

$4.32 - $18.56

Market Cap

$868.26M

P/E Ratio

0.00

Dividend (Yield)

N/A (N/A)

Volume

275,035

Average Daily Volume

278,000

THRX VS S&P 500 (SPY)

Caps

Motley Fool CAPS is a community working together to find better stocks and to become better investors.

Sell Dendreon! No, Buy Dendreon!April 14, 2009 – The Motley Fool
Rocket Stock or Dud?March 30, 2009 – The Motley Fool
Dyax: A Cinderella Story Ends in a FallMarch 27, 2009 – The Motley Fool
Wyeth: Now Approved to Kill More Bugs!March 25, 2009 – The Motley Fool
Taking the F Out of FDAMarch 24, 2009 – The Motley Fool
Roses and Candy From the FDA?February 10, 2009 – The Motley Fool
Not If, but When, for LillyFebruary 04, 2009 – The Motley Fool
The FDA Needs a Bake SaleDecember 30, 2008 – The Motley Fool
The FDA's Killing Bug KillersNovember 28, 2008 – The Motley Fool
Updated FDA Calendar of 75 Decision Dates November 21, 2008 – Blog at The Motley Fool
One Share Offering Too Many for Vertex?September 24, 2008 – The Motley Fool
Johnson & Johnson Gets RejectedAugust 21, 2008 – The Motley Fool
No Love for Antibiotics From the FDAMay 30, 2008 – The Motley Fool
Discovery's Costly Debt DelayMay 28, 2008 – The Motley Fool
5 Deathbed StocksApril 23, 2008 – The Motley Fool
The FDA's Call for CashMarch 03, 2008 – The Motley Fool
FDA's Mixed Signals for TheravanceFebruary 28, 2008 – The Motley Fool
Resources for Rx StocksFebruary 20, 2008 – The Motley Fool
Seattle Genetics' Good TimingJanuary 22, 2008 – The Motley Fool
Better Safe Than Sorry at TheravanceJanuary 16, 2008 – The Motley Fool